Moreover, the inhibition of HIF-1α and VEGF expression both at mRNA and protein levels has been reported to suppress tumor growth, whereas targeting mTOR/HIF-1α/VEGF can be considered as a promising strategy in anti-cancer therapy [58]. This evidence concerns the gene HIF1A and cancer.